SciELO - Scientific Electronic Library Online

 
vol.25 número5Balão Intragástrico no Tratamento da Obesidade: Segurança, Tolerância e EficáciaUma Causa Rara de Dor Abdominal num Doente com Pancreatite Aguda Necrotizante índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


GE-Portuguese Journal of Gastroenterology

versión impresa ISSN 2341-4545

Resumen

XAVIER, Sofia; MAGALHAES, Joana  y  COTTER, José. Proton Pump Inhibitors: Are They a Real Threat to the Patient?. GE Port J Gastroenterol [online]. 2018, vol.25, n.5, pp.243-252. ISSN 2341-4545.  https://doi.org/10.1159/000487154.

Background: Proton pump inhibitors are among the most frequently prescribed drugs in the world and are generally considered safe. However, there is growing concern regarding their safety. Summary: A nonsystematic review of the current literature was performed regarding proton pump inhibitors and their adverse effects. Proton pump inhibitors seem to be associated with fundic gland polyp development (without clinical relevance) and Clostridium difficile infection. Also, in cirrhotic patients, their prescription should be carefully reviewed. Regarding their association with other enteric infections, micronutrient deficiency, dementia, and chronic kidney disease, current evidence is still of low quality, and further studies are needed. Key Messages: Considering the current evidence, most patients with a clear clinical indication for proton pump inhibitor treatment should probably benefit from the maintenance of their treatment without significant adverse effects. However, higher-quality studies are needed to confirm or dismiss most of the proposed adverse effects.

Palabras clave : Proton pump inhibitors; Safety; Adverse effects.

        · resumen en Portugués     · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons